MACKENZIE ALEXANDER R 4
4 · PFIZER INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
PFIZER INCPFE
MACKENZIE ALEXANDER R
Executive Vice President
Transactions
- Exercise/Conversion
Stock Appreciation Rights
2020-02-28−37,934→ 0 totalExercise: $27.37From: 2020-02-28Exp: 2020-02-28→ Common Stock (37,934 underlying) - Tax Payment
Common Stock
2020-02-28$33.42/sh−9,760$326,179→ 130,496 total - Tax Payment
Common Stock
2020-02-28$36.45/sh−19,597$714,311→ 110,899 total - Exercise/Conversion
Common Stock
2020-02-28$27.37/sh+37,934$1,038,254→ 140,256 total
Holdings
- 9,715(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.